“Singapore plays a critical role as a centre for clinical excellence and regional influence, supporting broader adoption of advanced surgical technologies across Southeast Asia,” the company adds.
UltraGreen.ai (SGX:ULG
) announced that it secured regulatory approval for Verdye (indocyanine green for injection) in Singapore.
The company believes this approval is a strategic step in its Southeast Asia growth strategy, which will help in expanding its addressable market and strengthening its presence in a key regional healthcare hub.
